RCMI Coordinating Center (RCMI CC) Header Logo

Connection

George Perry to Gastric Inhibitory Polypeptide

Back to Details
This is a "connection" page, showing publications George Perry has written about Gastric Inhibitory Polypeptide.
George Perry
Connection Strength
0.245
Gastric Inhibitory Polypeptide
  1. da Silva AMP, Janu?rio Campos Cardoso L, Batista S, Gon?alves OR, Paranhos T, Teixeira IPS, Guimar?es PD, Espinosa Franco B, Cal H, Salles JEN, Perry G, H?ilund-Carlsen PF, Santos DH. Tirzepatide versus semaglutide for the prevention of mild cognitive impairment, dementia, and Alzheimer's disease in type 2 diabetes: A real-world, retrospective cohort study. J Diabetes Complications. 2026 May; 40(5):109306.
    View in: PubMed
    Score: 0.245
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support